About Sickle SCAN

Sickle SCAN® is a multiplexed qualitative point-of-care immunoassay used for the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of hemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell samples.

The test can be used for:
  1. Newborn screening
  2. Premarital/preconception genetic counseling Blood donor screening
  3. Blood donor screening
  4. General screening

Rapid and Easy Testing

The test can be completed in under 5 minutes giving real time results. It uses a small amount of whole blood from a fingerstick, heelstick, or venipuncture.

Compared to traditional central lab testing, Sickle SCAN® :
  1. Eliminates the need to transport samples
  2. Streamlines the clinical work flow
  3. Does not need supporting equipment or rigorous training
  4. Drastically reduces patient waiting time and discomfort

The Need

Currently, there are no rapid POC tests for sickle cell disease. Diagnosis is made using complex central lab equipment (HPLC and IEF) which have been incompatible for low-resource regions due to bulk size, lack of mobility, cost, difficulties in recruiting trained personnel and unreliable electricity supply. These factors have limited current diagnostic capabilities in low-resource regions, especially in remote and rural areas.

Sickle SCAN® is a simple but accurate rapid test that will help overcome the existing diagnostic gap in low-resource regions where SCD is responsible for 9% of all under-five infant mortality. The test can also be used preventatively for genetic counseling to reduce the incidence of sickle cell births.